perennial and controversial point - a business that is growing surer now of its footings, has to be considering how to leverage its market share gains in China and (hopefully) stronger US growth, to earn both a growth multiple on the SP and return some of that cash pile to shareholders.
- Forums
- ASX - By Stock
- A2M
- A2 SAMR APPROVED
A2M
the a2 milk company limited
Add to My Watchlist
0.96%
!
$7.73

A2 SAMR APPROVED, page-28
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.73 |
Change
-0.075(0.96%) |
Mkt cap ! $5.600B |
Open | High | Low | Value | Volume |
$7.87 | $7.87 | $7.71 | $5.094M | 657.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 7876 | $7.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.73 | 8678 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 9622 | 7.720 |
27 | 18018 | 7.710 |
28 | 28615 | 7.700 |
12 | 29034 | 7.690 |
12 | 15078 | 7.680 |
Price($) | Vol. | No. |
---|---|---|
7.730 | 8446 | 13 |
7.740 | 5651 | 14 |
7.750 | 22354 | 13 |
7.760 | 27515 | 14 |
7.770 | 6301 | 7 |
Last trade - 14.29pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online